Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:11-20, doi:10.1016/j.jcmg.2008.08.004
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Keeping an Eye on Imaging on CVN
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, S. M.
Right arrow Articles by Schiller, N. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stevens, S. M.
Right arrow Articles by Schiller, N. B.
Related Collections
Right arrowRelated Article

Development of an Echocardiographic Risk-Stratification Index to Predict Heart Failure in Patients With Stable Coronary Artery Disease

The Heart and Soul Study

Steven M. Stevens, MD*,*, Ramin Farzaneh-Far, MD*, Beeya Na, MPH{dagger}, Mary A. Whooley, MD*,{dagger}, Nelson B. Schiller, MD, FACC*

* Department of Medicine, Division of Cardiology, University of California, San Francisco, California
{dagger} Veterans Affairs Medical Center, San Francisco, California

* Reprint requests and correspondence: Dr. Steven M. Stevens, 10139 Woodly Avenue #112, North Hills, California 91343 (Email: drstevenstevens{at}gmail.com).

Objectives: We sought to determine which transthoracic echocardiographic (TTE) measurements most strongly predict heart failure (HF) and to develop an index for risk stratification in outpatients with coronary artery disease (CAD).

Background: Many TTE measurements have been shown to be predictive of HF, and they might be useful if aggregated into a risk-prediction index.

Methods: We performed TTE in 1,024 outpatients with stable CAD enrolled in the Heart and Soul study and followed them for 4.4 years. With Cox proportional hazard models, we evaluated the association of 15 TTE measurements with subsequent HF hospital stay. Those measurements that independently predicted HF were combined into an index. Variables were defined as normal or abnormal on the basis of dichotomous cutoffs determined from the American Society of Echocardiography. Abnormal variables in each measurement were assigned points on the basis of strength of association with HF.

Results: Of the 15 variables, 5 measurements were independent predictors of HF: left ventricular mass index (LVMI), left atrial volume index (LAVI), mitral regurgitation (MR), left ventricular outflow tract velocity-time integral (VTILVOT), and diastolic dysfunction (DD). In multivariate analysis, each of the 5 measurements independently predicted HF: LVMI >90 g/m2 (hazard ratio [HR]: 4.1; 95% confidence interval [CI]: 2.3 to 7.2, p < 0.0001); pseudo-normal or restrictive DD (HR: 2.9; 95% CI: 1.8 to 4.5, p < 0.0001); VTILVOT <22 mm (HR: 2.2; 95% CI: 1.4 to 3.5, p = 0.0004); mild, moderate, or severe MR (HR: 1.8; 95% CI: 1.2 to 2.8, p = 0.009); and LAVI >29 ml/m2 (HR: 1.6; 95% CI: 1.0 to 2.5, p < 0.06). Combining these measurements, the Heart Failure Index ranged from 0 to 8, representing risk as follows: 3 points for LVMI, 2 points for DD, and 1 point for VTILVOT, MR, and LAVI. Among participants with 0 to 2 points: 4% had HF hospital stays (reference); 3 to 4 points: 10% (HR: 2.4; 95% CI: 1.3 to 4.4, p = 0.003); 5 to 6 points: 24% (HR: 6.2; 95% CI: 3.6 to 10.6, p < 0.0001); 7 to 8 points: 48% (HR: 13.7; 95% CI: 7.2 to 25.9, p < 0.0001).

Conclusions: We identified 5 TTE measurements that independently predict HF in patients with stable CAD and combined them as an index that might be useful for risk stratification and serial observations.

Key Words: coronary artery disease • echocardiography • heart failure • prognostic index • risk stratification

Abbreviations and Acronyms
  CAD = coronary artery disease
  CI = confidence interval
  DD = diastolic dysfunction
  E/A = ratio of peak mitral early diastolic to atrial contraction velocity
  EF = ejection fraction
  HF = heart failure
  HR = hazard ratio
  LAVI = left atrial volume index
  LV = left ventricle/ventricular
  LVMI = left ventricular mass index
  LVOT = left ventricular outflow tract
  MR = mitral regurgitation
  NT-proBNP = N-terminal part of the pro-B-type natriuretic peptide
  TTE = transthoracic echocardiography
  VTILVOT = left ventricular outflow tract velocity–time integral
  VTIRVOT = right ventricular outflow tract velocity–time integral


Related Article

Role of Echocardiography in Predicting Onset of Heart Failure in Patients With Stable Coronary Artery Disease: Is the Whole Greater Than the Sum of its Parts?
Miguel A. Quinones
J. Am. Coll. Cardiol. Img. 2009 2: 21-23. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
M. A. Quinones
Role of echocardiography in predicting onset of heart failure in patients with stable coronary artery disease: is the whole greater than the sum of its parts?
J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 21 - 23.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link